Other groups have demonstrated that elevated expression of AKR1C3 can suppress differentiation of HL-60 tumor cells [28], [32] and promote angiogenesis of PC-3 tumor cells [33], both associated with a poor therapeutic outcome [34]. This evidence concerns the gene AKR1C3 and neoplasm.